Nkarta Balance Sheet Health

Financial Health criteria checks 6/6

Nkarta has a total shareholder equity of $430.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $532.0M and $101.2M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$283.06m
EquityUS$430.87m
Total liabilitiesUS$101.16m
Total assetsUS$532.03m

Recent financial health updates

Recent updates

Nkarta: Catalysts Ahead, But Competition In Cell Therapy Too (Rating Downgrade)

Oct 31

We're Hopeful That Nkarta (NASDAQ:NKTX) Will Use Its Cash Wisely

Sep 10
We're Hopeful That Nkarta (NASDAQ:NKTX) Will Use Its Cash Wisely

Nkarta: NK Cell Therapy Biotech With Good Standing Targeting R/R NHL Patients

Aug 14

Nkarta: A Look Into Q1 Results And Upcoming Catalysts

May 23

Nkarta: Down 50% Since March With A Clinical Catalyst Ahead

Apr 27

Nkarta: NK Cell Therapy Advancement On Two Fronts

Mar 25

Nkarta: Possible Upside From H1 Update, If Positive

Jan 25

Here's Why We're Watching Nkarta's (NASDAQ:NKTX) Cash Burn Situation

Jan 16
Here's Why We're Watching Nkarta's (NASDAQ:NKTX) Cash Burn Situation

We're Keeping An Eye On Nkarta's (NASDAQ:NKTX) Cash Burn Rate

Oct 04
We're Keeping An Eye On Nkarta's (NASDAQ:NKTX) Cash Burn Rate

We Think Nkarta (NASDAQ:NKTX) Can Afford To Drive Business Growth

Jun 21
We Think Nkarta (NASDAQ:NKTX) Can Afford To Drive Business Growth

We Think Nkarta (NASDAQ:NKTX) Can Afford To Drive Business Growth

Mar 06
We Think Nkarta (NASDAQ:NKTX) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Situation

Nov 20
Here's Why We're Not Too Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Situation

Nkarta GAAP EPS of -$0.61

Aug 11

We're Not Very Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Rate

Jun 09
We're Not Very Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Rate

Nkarta: A Promising Natural Killer Cell Play

May 20

We Think Nkarta (NASDAQ:NKTX) Can Afford To Drive Business Growth

Aug 23
We Think Nkarta (NASDAQ:NKTX) Can Afford To Drive Business Growth

Nkarta (NASDAQ:NKTX) Is In A Good Position To Deliver On Growth Plans

May 10
Nkarta (NASDAQ:NKTX) Is In A Good Position To Deliver On Growth Plans

Nkarta gets greenlight from the FDA for NKX019 cancer study

Apr 28

We're Not Very Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Rate

Jan 25
We're Not Very Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Rate

Financial Position Analysis

Short Term Liabilities: NKTX's short term assets ($290.2M) exceed its short term liabilities ($22.5M).

Long Term Liabilities: NKTX's short term assets ($290.2M) exceed its long term liabilities ($78.7M).


Debt to Equity History and Analysis

Debt Level: NKTX is debt free.

Reducing Debt: NKTX has no debt compared to 5 years ago when its debt to equity ratio was 19.8%.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: NKTX has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: NKTX has sufficient cash runway for 1.9 years if free cash flow continues to reduce at historical rates of 28.5% each year.


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 07:46
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nkarta, Inc. is covered by 14 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
William MaughanCanaccord Genuity
Alethia YoungCantor Fitzgerald & Co.
Joshua SchimmerEvercore ISI